MedTrace Logo

Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery

NCT05886218 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 215

Last updated 2025-05-15

No results posted yet for this study

Summary

This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.

Conditions

  • Sugammadex

Interventions

DEVICE

Quantitative Neuromuscular Function Monitoring

Quantitative electromyographic (EMG) monitoring

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-08
Primary Completion
2025-07-31
Completion
2025-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05886218 on ClinicalTrials.gov